Study Effect of the COVID-19 Lockdown on the Transition from Mild Cognitive Impairment to Dementia
DOI:
https://doi.org/10.55489/njcm.160620255183Keywords:
Alzheimer’s disease, Cognitive disorder, COVID-19, Dementia, Mild cognitiveAbstract
Background: Dementia represents a significant global health challenge, contributing to high fatality and frailty rates. The worldwide prevalence of dementia is projected to increase by 150% from 2018 to 2051. Countries with low to moderate incomes are expected to experience demographic shifts starting in 2017. The impact of the COVID-19 pandemic on cognitive decline is unclear, but increased social engagement is associated with a lower risk of dementia. We hypothesized that the first nationwide lockdown would lead to a rise in dementia diagnoses, accelerate cognitive decline in at-risk populations, and alter diagnostic patterns due to limited healthcare access.
Methodology: Data collection continued via telephone or audio-video calls during lockdowns, excluding participants with pre-existing dementia. Mild cognitive impairment (MCI) was defined using established criteria, with Clinical Dementia Rating (CDR) scores of 0.5 and Mini-Mental State Examination (MMSE) scores between 24 and 27. Poisson regression with cubic splines adjusted for age was used to estimate dementia incidence before and after 01-Mar-2020.
Results: Among 2140 participants, 200 were diagnosed with dementia before 20-Mar-2020, and 40 after. The incidence rate post-lockdown was not significantly different (p = 0.470). Secondary analysis revealed a decreased association between MCI and dementia after February 2020 (p = 0.021).
Conclusion: Dementia prevalence did not significantly change after the first lockdown. However, the relationship between MCI and dementia incidence weakened, possibly indicating faster progression to dementia or diagnostic challenges due to remote assessments.
References
Roberts R, Knopman DS Classification and epidemiology of MCI. Clin Geriatr Med. 2013;29(4):753‐772. DOI: https://doi.org/10.1016/j.cger.2013.07.003 PMid:24094295 PMCid:PMC3821397
Jia L, Du Y, Chu L, et al. Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross‐sectional study. Lancet Public Health. 2020;5(12):e661‐e671. DOI: https://doi.org/10.1016/S2468-2667(20)30185-7 PMid:33271079
Livingston G, Huntley J, Sommerlad A, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396(10248):413‐446. DOI: https://doi.org/10.1016/S0140-6736(20)30367-6 PMid:32738937
Velandia PP, Miller‐Petrie MK, Chen C, et al. Global and regional spending on dementia care from 2000-2019 and expected future health spending scenarios from 2020-2050: an economic modelling exercise. EClinicalMedicine. 2022;45:101337. DOI: https://doi.org/10.1016/j.eclinm.2022.101337 PMid:35299657 PMCid:PMC8921543
Thaipisuttikul P, Jaikla K, Satthong S, Wisajun P. Rate of conversion from mild cognitive impairment to dementia in a Thai hospital‐based population: a retrospective cohort. Alzheimer's Dement (N Y). 2022;8(1):e12272. DOI: https://doi.org/10.1002/trc2.12272 PMid:35386122 PMCid:PMC8970424
Burke D Review: long‐term annual conversion rate to dementia was 3.3% in elderly people with mild cognitive impairment. Evid Base Med. 2009;14(3):90. DOI: https://doi.org/10.1136/ebm.14.3.90 PMid:19483039
Mitchell AJ, Shiri‐Feshki M Temporal trends in the long term risk of progression of mild cognitive impairment: a pooled analysis. J Neurol Neurosurg Psychiatry. 2008;79(12):1386‐1391. DOI: https://doi.org/10.1136/jnnp.2007.142679 PMid:19010949
Chen YX, Liang N, Li XL, Yang SH, Wang YP, Shi NN. Diagnosis and treatment for mild cognitive impairment: a systematic review of clinical practice guidelines and consensus statements. Front Neurol. 2021;12:719849. DOI: https://doi.org/10.3389/fneur.2021.719849 PMid:34712197 PMCid:PMC8545868
Petersen RC, Lopez O, Armstrong MJ, et al. Practice guideline up- date summary: mild cognitive impairment: report of the guideline development, dissemination, and implementation subcommittee of the American Academy of neurology. Neurology. 2018;90(3): 126‐135. DOI: https://doi.org/10.1212/WNL.0000000000004826 PMid:29282327 PMCid:PMC5772157
Sherman DS, Mauser J, Nuno M, Sherzai D. The efficacy of cognitive intervention in mild cognitive impairment (MCI): a meta‐analysis of outcomes on neuropsychological measures. Neuropsychol Rev. 2017;27(4):440‐484. DOI: https://doi.org/10.1007/s11065-017-9363-3 PMid:29282641 PMCid:PMC5754430
Zhaoyang R, Sliwinski MJ, Martire LM, Katz MJ, Scott SB. Features of daily social interactions that discriminate between older adults with and without mild cognitive impairment. J Gerontol B Psychol Sci Soc Sci. 2021. DOI: https://doi.org/10.1093/geronb/gbab019 PMid:33528558 PMCid:PMC10935459
Ferrante G, Camussi E, Piccinelli C, et al. Did social isolation during the SARS‐CoV‐2 epidemic have an impact on the lifestyles of citizens; Epidemiol Prev. 2020;44(5‐6 Suppl 2):353‐362. DOI: https://doi.org/10.19191/EP20.5‐6.S2.137
Grant F, Scalvedi ML, Scognamiglio U, Turrini A, Rossi L. Eating habits during the COVID‐19 lockdown in Italy: The nutritional and lifestyle side effects of the pandemic. Nutrients. 2021;13(7):2279. DOI: https://doi.org/10.3390/nu13072279 PMid:34209271 PMCid:PMC8308479
Sayin Kasar K, Karaman E Life in lockdown: social isolation, loneliness and quality of life in the elderly during the COVID‐19 pandemic: a scoping review. Geriatr Nurs. 2021;42(5):1222‐1229. DOI: https://doi.org/10.1016/j.gerinurse.2021.03.010 PMid:33824008 PMCid:PMC8566023
Kerr WC, Ye Y, Martinez P, et al. Longitudinal assessment of drinking changes during the pandemic: the 2021 COVID‐19 follow‐ up study to the 2019 to 2020 National Alcohol Survey. Alcohol Clin Exp Res. 2022;46(6):1050‐1061. DOI: https://doi.org/10.1111/acer.14839 PMid:35753040 PMCid:PMC9350305
Brown JK‐WE Coronovirus: A History of 'lockdown' Laws in England. House of Commons Library; 2021.
Collaborators GBDDF, Steinmetz JD, Vollset SE, et al. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2022;7(2):e105‐e125.DOI: https://doi.org/10.1016/s2468‐2667(21)00249‐8.
Beach B, Steel N, Steptoe A, Zaninotto P. Associations of cognitive impairment with self‐isolation and access to health and care during the COVID‐19 pandemic in England. Sci Rep. 2023;13(1):5026. DOI: https://doi.org/10.1038/s41598-023-31241-3 PMid:36977759 PMCid:PMC10043531
Perach R, Read S, Hicks B, et al. Predictors of loneliness during the Covid‐19 pandemic in people with dementia and their careers in England: findings from the DETERMIND‐C19 study. Aging Ment Health. 2022;27(3):1‐12. DOI: https://doi.org/10.1080/13607863.2022.2080179 PMid:35658781
Razai MS, Oakeshott P, Kankam H, Galea S, Stokes‐Lampard H. Mitigating the psychological effects of social isolation during the covid‐19 pandemic. BMJ. 2020;369:m1904. DOI: https://doi.org/10.1136/bmj.m1904 PMid:32439691
Manca R, De Marco M, Venneri A The impact of COVID‐19 infection and enforced prolonged social isolation on neuropsychiatric symptoms in older adults with and without dementia: a review. Front Psychiatry. 2020;11:585540. DOI: https://doi.org/10.3389/fpsyt.2020.585540 PMid:33192732 PMCid:PMC7649825
Douaud G, Lee S, Alfaro‐Almagro F, et al. SARS‐CoV‐2 is associated with changes in brain structure in UK Biobank. Nature. 2022;604(7907):697‐707. DOI: https://doi.org/10.1038/s41586-022-04569-5 PMid:35255491 PMCid:PMC9046077
Cheetham NJ, Penfold R, Giunchiglia V, et al. The effects of COVID‐ 19 on cognitive performance in a community‐based cohort: a COVID symptom study biobank prospective cohort study. E-Clinical Medicine. 2023;62:102086. DOI: https://doi.org/10.1016/j.eclinm.2023.102086 PMid:37654669 PMCid:PMC10466229
Carole H Sudre, Ayya Keshet, Mark S Graham, et al. Anosmia, ageusia, and other COVID-19-like symptoms in association with a positive SARS-CoV-2 test, across six national digital surveillance platforms: an observational study 2021. Lancet Digit Health 2021; 3: e577-86. DOI: https://doi.org/10.1016/S2589-7500(21)00115-1 PMid:34305035
Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang C, McCarthy P, et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022;604(7907):697-707. DOI: https://doi.org/10.1038/s41586-022-04569-5 PMid:35255491 PMCid:PMC9046077
Hampshire A, Trender W, Chamberlain SR, Jolly AE, Grant JE, Patrick F, et al. Cognitive deficits in people who have recovered from COVID-19. E Clinical Medicine. 2021;39(101044):101044. DOI: https://doi.org/10.1016/j.eclinm.2021.101044 PMid:34316551 PMCid:PMC8298139
Thornicroft G, Sunkel C, Alikhon Aliev A, Baker S, Brohan E, el Chammay R, et al. The Lancet Commission on ending stigma and discrimination in mental health. Lancet. 2022;400(10361):1438-80. DOI: https://doi.org/10.1016/S0140-6736(22)01470-2 PMid:36223799
Maxime Taquet, John R Geddes, Masud Husain, Sierra Luciano, Paul J Harrison. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021; 8: 416-427. DOI: https://doi.org/10.1016/S2215-0366(21)00084-5 PMid:33836148
Klein J, Wood J, Jaycox JR, Dhodapkar RM, Lu P, et al. Distinguishing features of long COVID identified through immune profiling. Nature. 2023;623(7985):139 DOI: https://doi.org/10.1038/s41586-023-06651-y PMid:37748514 PMCid:PMC10620090
Lowe DA, Balsis S, Miller TM, Benge JF, Doody RS. Greater precision when measuring dementia severity: establishing item parameters for the Clinical Dementia Rating Scale. Dement Geriatr Cogn Disord. 2012;34(2):128‐134. DOI: https://doi.org/10.1159/000341731 PMid:23006935 PMCid:PMC3557804
Francis PT, Hayes GM, Costello H, Whitfield DR. Brains for dementia research: the importance of cohorts in brain banking. Neu- rosci Bull. 2019;35(2):289‐294. DOI: https://doi.org/10.1007/s12264-018-0327-2 PMid:30604278 PMCid:PMC6426925
Cedarbaum JM, Jaros M, Hernandez C, et al. Rationale for use of the Clinical Dementia Rating Sum of Boxes as a primary outcome measure for Alzheimer's disease clinical trials. Alzheimers Dement. 2013;9(1 Suppl l):S45‐S55. DOI: https://doi.org/10.1016/j.jalz.2011.11.002 PMid:22658286
StataCorp. Stata Statistical Software: Release. Vol 17. StataCorp LLC; 2021.
Stephan Y, Sutin AR, Luchetti M, Terracciano A. Subjective age and risk of incident dementia: evidence from the national health and aging trends survey. J Psychiatr Res. 2018;100:1‐4. DOI: https://doi.org/10.1016/j.jpsychires.2018.02.008 PMid:29471080 PMCid:PMC5866231
Harrell FE Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis. Springer‐Verlag; 2001. DOI: https://doi.org/10.1007/978-1-4757-3462-1
Ishikawa KM, Davis J, Chen JJ, Lim E. The prevalence of mild cognitive impairment by aspects of social isolation. PLoS One. 2022;17(6):e0269795. DOI: https://doi.org/10.1371/journal.pone.0269795 PMid:35700220 PMCid:PMC9197049
Norgaard M, Ehrenstein V, Vandenbroucke JP Confounding in observational studies based on large health care databases: prob- lems and potential solutions-a primer for the clinician. Clin Epi- demiol. 2017;9:185‐193. DOI: https://doi.org/10.2147/CLEP.S129879 PMid:28405173 PMCid:PMC5378455
Beishon LC, Elliott E, Hietamies TM, et al. Diagnostic test accuracy of remote, multidomain cognitive assessment (telephone and video call) for dementia. Cochrane Database Syst Rev. 2022;4:CD013724. DOI: https://doi.org/10.1002/14651858.CD013724.pub2 PMid:35395108 PMCid:PMC8992929
Herr M, Ankri J A critical review of the use of telephone tests to identify cognitive impairment in epidemiology and clinical research. J Telemed Telecare. 2013;19(1):45‐54. DOI: https://doi.org/10.1177/1357633X12474962 PMid:23390209
Katz MJ, Wang C, Nester CO, et al. A valid phone screen for cognitive impairment in diverse community samples. Alzheimers Dement (Amst). 2021;13(1):e12144. DOI: https://doi.org/10.1002/dad2.12144 PMid:33598528 PMCid:PMC7864219
Tsoi KK, Chan JYC, Hirai HW, Wong SYS, Kwok TCY. Cognitive tests to detect dementia: a systematic review and meta‐analysis. JAMA Intern Med. 2015;175(9):1450‐1458. DOI: https://doi.org/10.1001/jamainternmed.2015.2152 PMid:26052687
Kuiper JS, Zuidersma M, Oude Voshaar RC, et al. Social relationships and risk of dementia: a systematic review and meta‐analysis of longitudinal cohort studies. Ageing Res Rev. 2015;22:39‐57. DOI: https://doi.org/10.1016/j.arr.2015.04.006 PMid:25956016
Penninkilampi R, Casey AN, Singh MF, Brodaty H. The association between social engagement, loneliness, and risk of dementia: a systematic review and meta‐analysis. J Alzheimers Dis. 2018;66(4): 1619‐1633. DOI: https://doi.org/10.3233/JAD-180439 PMid:30452410
Evans IEM, Martyr A, Collins R, Brayne C, Clare L. Social isolation and cognitive function in later life: a systematic review and meta‐ analysis. J Alzheimers Dis. 2019;70(s1):S119‐S144. DOI: https://doi.org/10.3233/JAD-180501 PMid:30372678 PMCid:PMC6700717
Elovainio M, Lahti J, Pirinen M, et al. Association of social isolation, loneliness and genetic risk with incidence of dementia: UK Biobank Cohort Study. BMJ Open. 2022;12(2):e053936. DOI: https://doi.org/10.1136/bmjopen-2021-053936 PMid:35197341 PMCid:PMC8867309
Shen C, Rolls ET, Cheng W, et al. Associations of social isolation and loneliness with later dementia. Neurology. 2022;99(2). DOI: https://doi.org/10.1212/WNL.0000000000200583 PMCid:PMC9536742
Yu B, Steptoe A, Chen Y, Jia X. Social isolation, rather than loneli- ness, is associated with cognitive decline in older adults: the China Health and Retirement Longitudinal Study. Psychol Med. 2021; 51(14):1‐8. DOI: https://doi.org/10.1017/S0033291720001014 PMid:32338228
Lara E, Martín‐María N, De la Torre‐Luque A, et al. Does loneliness contribute to mild cognitive impairment and dementia? A systematic review and meta‐analysis of longitudinal studies. Ageing Res Rev. 2019;52:7‐16. DOI: https://doi.org/10.1016/j.arr.2019.03.002 PMid:30914351
Holwerda TJ, Deeg DJH, Beekman ATF, et al. Feelings of loneliness, but not social isolation, predict dementia onset: results from the Amsterdam Study of the Elderly (AMSTEL). J Neurol Neurosurg Psy- chiatry. 2014;85(2):135‐142. DOI: https://doi.org/10.1136/jnnp-2012-302755 PMid:23232034
Sundstrom A, Adolfsson AN, Nordin M, Adolfsson R. Loneliness in- creases the risk of all‐cause dementia and Alzheimer's disease. J Gerontol B Psychol Sci Soc Sci. 2020;75(5):919‐926. DOI: https://doi.org/10.1093/geronb/gbz139 PMid:31676909 PMCid:PMC7161366
Drinkwater E, Davies C, Spires‐Jones TL Potential neurobiological links between social isolation and Alzheimer's disease risk. Eur J Neurosci. 2021;56(9):5397‐5412. DOI: https://doi.org/10.1111/ejn.15373 PMid:34184343
Holt-Lunstad J, Smith TB, Layton JB. Social relationships and mortality risk: A meta-analytic review. PLoS Med. 2010;7(7):1-20. DOI: https://doi.org/10.1371/journal.pmed.1000316 PMid:20668659 PMCid:PMC2910600
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Jigar Sanjiv Padhiar, Uddipak Rai, Reema Singh

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
The authors retain the copyright of their article, with first publication rights granted to Medsci Publications.